foxo4 dri peptide senolytic study FOXO4-DRI 10mg | Research FOXO4-DRI regulates endothelial cell senescence
FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway PMC FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data Development of a novel senolytic by precise disruption of FOXO4 p53 complex eBioMedicine FOXO4 DRI Peptide Potential Interactions with Aged Cell Cultures The disordered p53 transactivation domain is the target of FOXO4 and the senolytic compound FOXO4 DRI Nature Communications
Pay in 4 interest-free payments of $5.04 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 28 - Nov 2




